What are the indications for filgrastim?
- Chemotherapy-induced Febrile Neutropenia.
- Acute Myeloid Leukemia.
- Cancer Patients Receiving Bone Marrow Transplant.
- Peripheral Blood Progenitor Cell Collection and Engraftment.
- Severe Chronic Neutropenia.
Click to see full answer
Herein, when should Neupogen be given?
The recommended dosage of NEUPOGEN for the mobilization of autologous peripheral blood progenitor cells (PBPC) is 10 mcg/kg/day given by subcutaneous injection. Administer NEUPOGEN for at least 4 days before the first leukapheresis procedure and continue until the last leukapheresis.
Additionally, what is Filgrastim used to treat? Filgrastim injection is used to treat neutropenia (low white blood cells) that is caused by cancer medicines. It is a synthetic (man-made) form of a substance that is naturally produced in your body called a colony stimulating factor. Filgrastim helps the bone marrow to make new white blood cells.
In this way, when should filgrastim be given?
The manufacturer recommends that the first dose of filgrastim be given no sooner than 24 hours after chemotherapy. Your doctor will discontinue therapy with filgrastim when your white blood cell count has reached acceptable levels.
What type of drug is filgrastim?